A service of StreetInsider.com
Welcome

Most Popular

AAPL 196.19
C 3.18
GOOG 536.44
BAC 14.47
RIMM 66.15

Recently Added

TNGN 0.00
SWS 12.17
ATHX 2.88
MED 17.54
DANA 0.20

Gaining Speed

CTGI 0.14
MKSI 18.55
HLXW 1.03
SPGZ 1.83
TNGN 0.00
4.01 -0.16 (-3.87%) NYMX

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:4.01 Change:-0.16 (-3.87%) Prev Close:4.17 Open: 4.13 Days Range:3.85 – 4.33 52 Week Range: 2.67 - 7.07 Volume:121985 P/E: N/A
EPS:-0.13

Member Comments

No member comments available for NYMX


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 02/10/10

Recent Alert on 01/07/10 at 11:02am
Nymox Pharma (NYMX) Announces Publication of NX-1207 BPH Treatment

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today the publication of a new peer-reviewed paper in Expert Opinion on Investigational Drugs featuring NX-1207, the Company's innovative treatment for benign prostatic hyperplasia (BPH). ... Read More

Recent Alert on 01/07/10 at 11:02am
Nymox Pharma (NYMX) Announces Publication of NX-1207 BPH Treatment
Recent Alert on 11/23/09 at 10:53am
Nymox Pharmaceutical (NYMX) Announces Positive Clinical Data on BPH Drug NX-1207
Recent Alert on 11/13/09 at 9:46am
Nymox Pharmaceutical (NYMX) Swings to Q3 Loss of 4c

View AllRecent Press Releases

Press Release on 02/09/10 at 11:44am
Nymox Provides Update on Pivotal Phase 3 Trials for BPH Drug

View AllRecent SEC Filings

No Recent SEC Filings Available

View AllRecent Blog Posts

Blog Posts on 12/21/09 at 3:41pm
The Complete List of Canadian Stocks Traded on the Nasdaq
Blog Posts on 06/21/09 at 7:03am
15 Possible Healthcare Breakout Stocks
Blog Posts on 02/07/08 at 5:00am
Option update: CME Group volatility spikes as CME sells off 17% on DOJ view